UNITED STATES ANTIMONY CORP (UAMY): US Antimony Corporation Third Quarter 2026 Financial and Operational Results
UNITED STATES ANTIMONY CORP (UAMY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Transcript of United States Antimony Corporation US Antimony Corporation Third Quarter 2026 Financial and Operational Results November 12, 2026 Participants Gary Evans - Chairman and Chief Executive Officer, United States Antimony Corporation Shawn Winkler - Senior V
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
The company provided updated full-year 2026 volume guidance and detailed DLA shipment status, including cycle-time improvement to about 70 days and remaining contracted DLA sales through 2029.
Market read
Traders can update expectations for 2026 antimony volumes and gross margin trajectory based on the new guidance and DLA execution metrics, while monitoring delivery acceptance timing risk.
What to watch
A large portion of the net loss includes a $3.8M non-cash loss on the Larvotto strategic investment, which may dampen longer-term earnings quality despite operating improvements.
Q3 2026 revenue of $10.1 million, up 16%; gross profit $4.3 million; net loss $9.5 million, or $0.06 per share
Antimony volume and revenue grew and management reports gross margin of 42%, but the quarter still produced a net loss of $9.5 million, operating expenses rose to $10.3 million, DLA revenue depends on acceptance timing the company says it does not control, and full-year revenue guidance was replaced by volume guidance.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Revenue, Q3 2026other | $10.1M | 28% | – |
| Gross profit, Q3 2026other | $4.3M | – | – |
| Gross profit margin, Q3 2026other | 42% | – | – |
| Antimony pounds sold, Q3 2026other | about 469,000 pounds | – | 68% |
| Antimony pounds sold to DLA, Q3 2026other | about 162,000 pounds | – | – |
| Antimony sales to DLA, Q3 2026 (sales price in aggregate)other | about $5.1 million | – | – |
| Antimony pounds sold to industrial customers, Q3 2026other | about 307,000 pounds | – | – |
| Antimony revenue from industrial customers, Q3 2026other | about $3.7 million | – | – |
| Cost per pound sold, Q3 2026other | $10.19 | – | – |
| ATO pounds sold, Q3 2026 (change only, level not printed)other | rose 10% year-on-year, level not printed | – | 10% |
| Zeolite revenue, Q3 2026other | approximately $1.04 million | – | 55% |
| Operating expenses, Q3 2026other | $10.3M | – | – |
| Exploration spending within operating expenses, Q3 2026other | $3.4M | – | – |
| Non-cash loss on Larvotto strategic investment, Q3 2026other | $3.8M | – | – |
| Net loss, Q3 2026other | $9.5M | – | – |
| Net loss per share, Q3 2026other | $0.06 per share | – | – |
| Capital projects invested, nine months 2026other | $28.4M | – | – |
| Department of War grant proceeds realized, nine months 2026other | $12.8M | – | – |
| Cash, cash equivalents and treasuries, September 30 2026other | $51M | – | – |
| Larvotto shares value (as stated on the call)other | $39.4M | – | – |
| Inventory, September 30 2026other | $28.1M | – | – |
| Stock repurchases through October 2026other | about $3.1 million | – | – |
| DLA shipments delivered and accepted and paid, year to dateother | seven shipments, about 276,000 pounds, about $8.7 million in revenue | – | – |
| Sales to DLA contracted through 2029other | $48.6M | – | – |
| Annual revenue, 2025 (as stated in IR remarks)other | more than $39 million | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Antimony sales to DLASales to the Defense Logistics Agency in Q3 2026. Management said DLA deliveries depend on DLA approvals at several steps and that cycle time is not fully within the company's control. | about $5.1 million (about 162,000 pounds) | – | – |
| Antimony sales to industrial customersSales primarily to industrial customers in Q3 2026. The CFO described the industrial business as holding up well, with ATO pounds sold up 10% year-on-year. | about $3.7 million (about 307,000 pounds) | – | – |
| ZeoliteZeolite revenue for Q3 2026, rising 55% year-on-year as stated by the CFO. | approximately $1.04 million | – | 55% |
Full year 2026 outlook
- NoteAntimony sales volume of 1.68 million to 1.81 million pounds, up 24% at the midpoint year-on-year
- NoteAntimony sales to DLA of 276,000 to 356,000 pounds in total; the low end includes no further DLA deliveries this year and the high end includes two more trucks to be accepted
- NoteZeolite sales of 17,500 to 18,500 tons
- NoteRevenue guidance of $60 million to $75 million was replaced by volume guidance, which the company said reflects that revenue depends on delivery speed and market prices it cannot control
- NoteVolumes to DLA not delivered in 2026 move into 2027 and are not lost, according to the company
Capital returns
- About $3.1 million of stock repurchased through October 2026
- $96.9 million still authorized under the repurchase program (the CFO corrected the figure from $98.3 million on the call)
- The August 2026 Board authorization allows repurchases of up to $100 million
- Certain directors, including the CEO and senior management, made additional open market purchases of UAMY shares during the quarter
What drove it
- Antimony pounds sold rose 68% year-on-year to about 469,000 pounds, according to the CFO
- Management attributes the revenue increase of 16% and the sequential increase of 28% to volume growth in antimony sales, including DLA deliveries
- The CEO said gross profit margin expanded to 42% from 23% in a declining market, and described margins as the main focus of the quarter
- The CFO said cost per pound sold fell to $10.19 from $20.89, which he said largely reflects broader antimony pricing
- Operating expenses increased to $10.3 million, and the CFO said $3.4 million of that was directed to exploration
- Net loss included a $3.8 million non-cash loss on the Larvotto strategic investment, as the CFO described it
- Radersburg moved into its operating phase in Q3 2026 and is in a short shutdown to install new flotation equipment
- Stibnite Hill mining restarted in July 2026, and close to 2,000 tons have been trucked to the Radersburg mill, per the CEO
Concerns
- Net loss of $9.5 million, or $0.06 per share, in the quarter
- Operating expenses of $10.3 million, including $3.4 million of exploration spending
- Non-cash loss of $3.8 million on the Larvotto investment
- DLA revenue timing: the CFO said the company cannot control DLA release, and recent shipments took about 70 days from sampling to delivery
- Full-year revenue guidance was replaced with volume guidance, so the company gave no revenue target for 2026
- Management said the Bolivia hydromet facility has delivered well below the 150 tons per month expected earlier in 2026, and that the company is not counting on it
- Management described Thompson Falls delivery delays caused by furnace parts, staffing, and a contractor dispute; the company said the ramp is slower than planned
- The CEO said liquidity has stayed basically stagnant all year as capital spending continued
What to watch
- DLA lots 8 to 11, about 122,000 pounds sampled in early October 2026, with delivery and acceptance timing still to be determined
- Whether DLA lots 12 to 14 are delivered and accepted in 2026, and how much of the 276,000 to 356,000 pound DLA range is achieved
- Processing of Stibnite Hill ore at Radersburg and Madero before year end, per management
- Nolan Creek 1,000-ton bulk sample, which management hopes to receive before year end, subject to MSHA approval
- Completion of Radersburg flotation upgrades and the second phase of hiring and shift expansion
- Fastmarkets' planned new American antimony price, which management said should be beneficial
- Progress on Fostung Tungsten and Nolan Creek, which management said it expects to report on in early 2027
- Government funding proposals: $36 million requested federal funding in a $45 million project proposal, and two DIBC proposals totaling about $110 million, all under consideration and not awarded
- Liquidity after collection of amounts due from the government and repayment of notes due to the company, which management expects to improve liquidity by year end
Balance sheet and cash flow
- Cash and treasuries of $51 million at September 30 2026
- Larvotto shares valued at $39.4 million, as stated on the call
- Margin line of $19 million with nothing drawn
- Inventory of $28.1 million, staged for DLA deliveries; the CEO described inventory as at record highs
- Capital projects of $28.4 million invested in the nine months, mainly the Thompson Falls expansion and Radersburg, partly offset by $12.8 million of Department of War grant proceeds realized
- Of $27.0 million in total grants awarded, $20.3 million has been authorized and $12.8 million realized
- Operating cash flow and free cash flow were not discussed in the filing text
Analysis
Management reported Q3 2026 revenue of $10.1 million, which the CFO said was up 16%, and up 28% from Q2. Antimony pounds sold were about 469,000, up 68% year-on-year. The split was about 162,000 pounds sold to the DLA, valued at about $5.1 million in aggregate, and about 307,000 pounds sold to industrial customers, generating about $3.7 million. Zeolite revenue was approximately $1.04 million, up 55% year-on-year. The filing does not print prior-period revenue or a prior-period figure for the 16% change, so the comparison period is not fixed from the text. The filing does not print a prior-period figure for gross margin either; the CEO said margin expanded to 42% from 23%.
Gross profit was $4.3 million, and the CEO described gross margin as the key result of the quarter in a declining antimony market. The CFO said cost per pound sold fell to $10.19 from $20.89, and attributed that largely to broader antimony pricing. The company is therefore reporting higher volume and a higher gross margin on a per-pound basis, against a lower market price. Management said it has rejected some customer orders over the last 60 to 90 days because pricing was too low.
Below gross profit, operating expenses were $10.3 million, including $3.4 million of exploration spending. The net loss was $9.5 million, or $0.06 per share, and included a $3.8 million non-cash loss on the Larvotto investment. The filing does not give a prior-period net loss, so no change is stated. The filing does not state whether the net loss figure is on a GAAP basis, and the release itself is not in the document text.
On capital, the company invested $28.4 million in capital projects over nine months, mainly the Thompson Falls expansion and Radersburg, partly offset by $12.8 million of Department of War grant proceeds realized. Cash and treasuries were $51 million at September 30 2026, with nothing drawn on a $19 million margin line. Inventory rose to $28.1 million, which the CFO said reflects material staged for DLA deliveries. Stock repurchases of about $3.1 million were made through October, with $96.9 million remaining under the authorization. Management also gave volume guidance for 2026 in place of the previous $60 million to $75 million revenue guidance, and the company did not provide a revenue target for 2026. The guidance range is 1.68 million to 1.81 million pounds, up 24% at the midpoint, with DLA volumes between 276,000 and 356,000 pounds, the low end of which includes no further DLA deliveries this year.
Management, verbatim
The margins should be the thing everybody focuses on. I think shareholders will reward us much better with stronger margins versus sales with limited margins.
Gary Evans, Chairman and Chief Executive Officer, United States Antimony Corporation
Our share price has declined significantly over the last half year, and we recognize the frustration that situation creates for existing shareholders.
Jonathan Miller, Vice President, Investor Relations and Global Sales Manager, United States Antimony Corporation
The DLA evaluates our sampling, and then we ship, and then they test again.
Shawn Winkler, Senior Vice President and Chief Financial Officer, United States Antimony Corporation
Not in the filing
stated, not guessed- The Form 8-K text contains the earnings call transcript only; the earnings press release and the 10-Q referenced by the CFO are not in the document text
- Consolidated income statement (press release) with total revenue for the prior-year quarter, prior-quarter comparisons, and nine-month and full-year comparisons
- Prior-year quarter revenue, gross profit and gross margin with the period explicitly identified; the 16% revenue change, the 113% gross profit change and the 23% prior gross margin are not tied to a stated period in the text
- Prior-period comparison for cost per pound sold of $20.89 (period not stated)
- Prior-year and prior-quarter net loss and net loss per share
- Basis (GAAP or non-GAAP) for revenue, gross profit, operating expenses, net loss and net loss per share
- Cost of sales, operating income, interest expense, income tax and other operating expense line items
- Operating cash flow, free cash flow and capital expenditure for the quarter
- Total assets, total liabilities and total equity as of September 30 2026
- Nine-month revenue, net loss and gross profit
- Previous release OUTLOOK section, which was not provided, so the prior guidance comparison could not be made; the $60 million to $75 million prior revenue guidance is named on the call only
- Share count and per-share data beyond the loss per share figure
- Date of the Larvotto share valuation of $39.4 million
- Exact amount of the 2025 revenue beyond the figure stated as 'more than $39 million'
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
The SEC 8-K furnishes the Q3 and nine-month 2026 financial and operational results conference call transcript, including DLA shipment progress and full-year 2026 guidance.
Ticker impact
US Antimony reported Q3 revenue $10.1M (+16%), gross margin 42%, and initiated full-year 2026 antimony volume guidance tied to DLA deliveries.
Likely positive bias as traders price in higher volumes and improved gross margin, tempered by uncertainty around DLA acceptance timing.
The filing provides fresh operational metrics (pounds sold, gross margin expansion) and a new full-year 2026 volume guidance framework, but it also flags that DLA approvals and acceptance timing are not fully controllable.
Market effects
Adds datapoints on antimony supply execution and margin sensitivity to market pricing, relevant for specialty metals sentiment.
No clear regional market linkage beyond Montana operations and grant-funded expansion.
Limited, as the disclosure is company-specific and does not describe global antimony supply shocks.
Counterpoint
The guidance is volume-focused and explicitly depends on DLA approvals and acceptance timing, so near-term results could still be lumpy despite higher reported Q3 volumes.
Key entities
- issuerUnited States Antimony Corporation
Reported Q3 2026 results, DLA shipment progress, and initiated full-year 2026 antimony and zeolite volume guidance.
- counterpartyDefense Logistics Agency (DLA)
Government buyer referenced for antimony shipments, approvals, and acceptance timing that affect delivery schedules.
- investmentLarvotto strategic investment
Referenced as a source of a $3.8M non-cash loss impacting net loss.



